No association of presenilin-1 intronic polymorphism and Alzheimer's disease in Australia

Neurosci Lett. 1998 May 1;246(3):178-80. doi: 10.1016/s0304-3940(98)00248-1.

Abstract

We screened 703 Australian subjects for an intronic polymorphism in the presenilin-1 (PS-1) gene. PS-1 intronic allele 1 homozygosity was not associated with individuals with early- or late-onset sporadic Alzheimer's disease (EOAD or LOAD). Carriers for the PS-1 intronic allele 1 were also not associated with significantly increased risk for AD regardless of gender. Our results for the Australian population are consistent with those of recent reports for other populations and do not support the conclusion that the PS-1 intronic polymorphism is associated with AD.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4
  • Apolipoproteins E / genetics
  • Australia
  • DNA / analysis
  • DNA Mutational Analysis / statistics & numerical data
  • Female
  • Gene Frequency
  • Genetic Linkage
  • Genetic Testing
  • Genotype
  • Humans
  • Introns / genetics*
  • Leukocytes / chemistry
  • Logistic Models
  • Male
  • Membrane Proteins / genetics*
  • Middle Aged
  • Polymorphism, Genetic*
  • Presenilin-1

Substances

  • Apolipoprotein E4
  • Apolipoproteins E
  • Membrane Proteins
  • PSEN1 protein, human
  • Presenilin-1
  • DNA